Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia (CONNECT)

This study has been terminated.
(Following a pre-specified interim analysis and Data Monitoring Committee recommendation due to insufficient level of efficacy)
Sponsor:
Information provided by (Responsible Party):
Sanofi
ClinicalTrials.gov Identifier:
NCT00439634
First received: February 22, 2007
Last updated: April 18, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 18, 2016